Literature DB >> 10953955

Uncommon mutations and polymorphisms in the hemochromatosis gene.

J J Pointon1, D Wallace, A T Merryweather-Clarke, K J Robson.   

Abstract

Hereditary hemochromatosis (HH) is a common autosomal recessive disorder of iron metabolism. Iron absorption from the gut is inappropriately high, resulting in increasing iron overload. The hemochromatosis gene (HFE) was identified in 1996 by extensive positional cloning by many groups over a period of about 20 years. Two missense mutations were identified. Homozygosity for one of these, a substitution of a tyrosine for a conserved cysteine (C282Y), has now clearly been shown to be associated with HH in 60-100% of patients. The role of the second mutation, the substitution of an aspartic acid for a histidine (H63D), is not so clear but compound heterozygotes for both these mutations have a significant risk of developing HH. Here we review other putative mutations in the HFE gene and document a number of diallelic polymorphisms in HFE introns.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10953955     DOI: 10.1089/10906570050114867

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  15 in total

1.  Diagnostic testing fails the test.

Authors:  Jon F Merz; Antigone G Kriss; Debra G B Leonard; Mildred K Cho
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

2.  Clinical utility gene card for: Haemochromatosis [HFE].

Authors:  Manfred Stuhrmann; Heinz Gabriel; Stephen Keeney
Journal:  Eur J Hum Genet       Date:  2010-02-03       Impact factor: 4.246

3.  H63D mutation in HFE gene is common in Indians and is associated with the European haplotype.

Authors:  Barjinderjit Kaur Dhillon; Swami Prakash; G R Chandak; Y K Chawla; Reena Das
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

4.  Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.

Authors:  Monique G Zaahl; Alison T Merryweather-Clarke; Maritha J Kotze; Schalk van der Merwe; Louise Warnich; Kathryn J H Robson
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

Review 5.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.

Authors:  Nicholas J Osborne; Lyle C Gurrin; Katrina J Allen; Clare C Constantine; Martin B Delatycki; Christine E McLaren; Dorota M Gertig; Gregory J Anderson; Melissa C Southey; John K Olynyk; Lawrie W Powell; John L Hopper; Graham G Giles; Dallas R English
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

Review 7.  Recent advances in understanding haemochromatosis: a transition state.

Authors:  K J H Robson; A T Merryweather-Clarke; E Cadet; V Viprakasit; M G Zaahl; J J Pointon; D J Weatherall; J Rochette
Journal:  J Med Genet       Date:  2004-10       Impact factor: 6.318

8.  An unhappy triad: hemochromatosis, porphyria cutanea tarda and hepatocellular carcinoma-a case report.

Authors:  Martina-T Mogl; Andreas Pascher; Sabine-J Presser; Michael Schwabe; Peter Neuhaus; Natascha-C Nuessler
Journal:  World J Gastroenterol       Date:  2007-04-07       Impact factor: 5.742

9.  Hereditary haemochromatosis gene (HFE) H63D mutation shows an association with abnormal sperm motility.

Authors:  Aysen Gunel-Ozcan; M Murad Basar; Ucler Kisa; Handan C Ankarali
Journal:  Mol Biol Rep       Date:  2008-10-10       Impact factor: 2.316

10.  Analysis of HFE and non-HFE gene mutations in Brazilian patients with hemochromatosis.

Authors:  Paulo Lisboa Bittencourt; Maria Lúcia Carnevale Marin; Cláudia Alves Couto; Eduardo Luiz Rachid Cançado; Flair José Carrilho; Anna Carla Goldberg
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.